Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

MOZOBIL vs SARCLISA ESCENA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. MOZOBIL and SARCLISA ESCENA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

mozobilsarclisa escena

Rating

70/100
70/100

Pharmacy pays

—
—

Type

RX
RX

Active ingredient

PLERIXAFOR
ISATUXIMAB-IRFC

Manufacturer

Genzyme
Sanofi-Aventis U.S. LLC

Dosage forms

Injectable
Injectable

Drug class

Hematopoietic Stem Cell Mobilizer
—

Boxed warning

None
None

Treats

Non-Hodgkin Lymphoma, Multiple Myeloma
Multiple Myeloma

Frequently asked questions

Which is better-rated, Mozobil or Sarclisa Escena?

Mozobil and Sarclisa Escena are tied at 3.5 out of 5 by our independent rating.

What is the difference between Mozobil and Sarclisa Escena?

Mozobil contains Plerixafor, while Sarclisa Escena contains Isatuximab-Irfc — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.